600530.SH
ST交昂
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 3.61
−2.43%Margins
Gross margin
30.3%
EBITDA margin
14.0%
EBIT margin
4.6%
Net margin
1.3%
FCF margin
17.4%
1.3%
Return on equity
0.6%
Return on assets
3.2%
Return on invested capital
0.42x
Asset turnover
CNY 57.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026